ASSTON PHARMACEUTICALS LIMITED

09 Jul 2025 - 11 Jul 2025 Individual Category SME BSE

Min Investment

₹123000

Price Band

₹115-₹123

Issue Size

16.06 lakhs
Equity Shares

Lot Size

1000

IPO Dates
img

09 Jul 2025

Open Date

img

11 Jul 2025

Close Date

img

14 Jul 2025

Allotment Date

img

16 Jul 2025

Listing Date

Asston Pharmaceuticals IPO open date is July 9, 2025, and the closing date is July 11, 2025. This upcoming IPO is offering total issue size of 22.41 lakh equity shares with a combination of fresh issue and offer for sale. Asston Pharmaceuticals IPO is a book-built issue with issue price band Rs 115 – Rs 123 per share. As of now, Asston Pharmaceuticals IPO GMP Live quotation is not yet available. Asston Pharmaceuticals IPO allotment status is available on July 14, 2025. Asston Pharmaceuticals IPO lot size is 2000 shares. The minimum investment for the retail investors is 1 lot of Rs 2,46,000. The registrar for Asston Pharmaceuticals IPO is Maashitla Securities Private Limited. Asston Pharmaceuticals IPO listing date is July 16, 2025.

Know Before Investing

Strengths icon

  • In-house QA systems ensure high product quality and compliance.
  • Strong leadership and skilled team support effective operations and planning.
  • Proximity to ports enhances logistics efficiency for domestic and global markets.

Weaknesses icon

  • Export-focused model is vulnerable to global market and currency risks.
  • Limited logistics tie-ups reduce adaptability in international supply chains.
  • Relying on a single freight forwarder risks delivery disruptions.

About Asston Pharmaceuticals Limited

Asston Pharmaceuticals Limited is a pharmaceutical and nutraceutical company established in 2019 in Navi Mumbai by Dr. Ashish Sakalkar, Mrs. Saili More, and Mr. Sachin Badakh. The company specializes in the development, manufacturing, and export of a diverse range of healthcare products, including tablets, capsules, syrups, ointments, powders, and injectables. With a strong focus on quality and affordability, Asston supplies its products to over 10 countries, particularly across South and West Africa, and is expanding into Asian markets. Its Ambernath facility is approved by regulators in Sierra Leone and Ghana, and the company collaborates with WHO GMP-certified manufacturers to ensure compliance and product safety. Asston’s portfolio features over 150 registered trademarks, covering generics, pediatric formulations, and specialized treatments. The company’s commitment to regulatory standards and strategic global partnerships supports its vision of delivering accessible healthcare worldwide.

Founded

2019

Managing Director

Dr. Ashish Narayan Sakalkar

Parent Organization

-

IPO Objectives

Asston Pharmaceuticals plans to utilise the IPO proceeds to fund capital expenditure for acquiring machinery in its manufacturing unit and to meet the company's incremental working capital requirements. The proceeds will also be directed towards the repayment or prepayment of certain outstanding borrowings, along with meeting general corporate purposes.

Company Promoters

Dr. Ashish Narayan Sakalkar

Saili Jayaram More

Sachin Chandrakant Badakh

Subscription Details

Investor Category Subscription (times)
Qualified Institutions 0
Non-Institutional Buyers 0
bNII (bids above ₹10L) 0
sNII (bids below ₹10L) 0
Retail Investors 0
Employees 0
Others 0
Total 0

How to Apply for IPO

img img

Login

Login to your Bigul Account

Select Lots & Price

Choose the number of lots and price

UPI ID

Enter your UPI ID

UPI Mandate Request

A UPI Mandate Request Triggered

Approve Mandate

Approve the UPI Mandate Request

IPO Allotment

YES Share will be credited. and the amount will be debited

Close

Let's Open Free Demat Account